Barclays analyst Tracy Benguigui maintains Allstate (NYSE:ALL) with a Equal-Weight and lowers the price target from $115 to $113.
Barclays lowers Allstate (NYSE:ALL) price target from $115 to $113 Read Post »
Allstate (NYSE:ALL) Q2 Adj $(4.42) Misses $(4.04) Estimate, Sales $12.62B Beat $12.52B Estimate.
Allstate (NYSE:ALL) reported Q2 loss widened to $5.29 per diluted share from a loss of $3.80 a year earlier. Analysts surveyed by Capital IQ expected a loss of $4.82. Revenue for the quarter ended June 30 was $13.98 billion, up from $12.22 billion a year earlier. Three of four analysts surveyed by Capital IQ expected $13.36 billion.
Allstate (NYSE:ALL) Q2 Loss Widens, Revenue Rises Read Post »
JPMorgan Cuts Allstate’s (NYSE:ALL) Price Target to $150 From $157, Maintains Overweight Rating.
JPMorgan Cuts Allstate’s (NYSE:ALL) Price Target to $150 From $157 Read Post »
Bank of America Securities analyst Joshua Shanker maintains Allstate (NYSE:ALL) with a Buy and raises the price target from $146 to $149.
Bank of America raised Allstate (NYSE:ALL) price target from $146 to $149 Read Post »
Wells Fargo analyst Elyse Greenspan maintains Allstate (NYSE:ALL) with a Underweight and lowers the price target from $104 to $100.
Wells Fargo lowered Allstate (NYSE:ALL) price target to $100 Read Post »
Piper Sandler analyst Paul Newsome maintains Allstate (NYSE:ALL) with a Overweight and raises the price target from $144 to $150.
Piper Sandler raised Allstate (NYSE:ALL) price target to $150 Read Post »
Bank of Montreal Capital analyst Michael Zaremski maintains Allstate (NYSE:ALL) with a Market Perform and lowers the price target from $130 to $120.
Bank of Montreal lowered Allstate (NYSE:ALL) price target from $130 to $120 Read Post »